483 Computer-Science "https:" "https:" "https:" "https:" "https:" positions at University of Colorado
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
and retirement contributions that add to your bottom line. Total Compensation Calculator: http://www.cu.edu/node/153125 Equal Employment Opportunity Statement: The University of Colorado (CU) is an
-
Compensation Calculator: http://www.cu.edu/node/153125 Equal Employment Opportunity Statement: The University of Colorado (CU) is an Equal Opportunity Employer and complies with all applicable federal, state
-
Matrix. Benefits: https://www.cu.edu/employee-services/benefits Total Compensation Calculator: http://www.cu.edu/node/153125 Application Deadline Applications will be accepted until finalists
-
– Requisition #:40806 Job Summary: The candidate will support a basic-translational research program focused on lung biology by analyzing high-throughput sequencing data, including bulk RNA-seq, single-cell RNA
-
, including children ages 3 and up. https://nursing.cuanschutz.edu/healthcare/locations/community-health Key Responsibilities: Upholds strict compliance with University and professional policies and procedures
-
Information Technology and CU Nursing Information Technology policies and procedures; problem diagnosis and resolution for computer software and hardware; assisting and educating end users regarding technology-related
-
contributions that add to your bottom line. Total Compensation Calculator: http://www.cu.edu/node/153125 Equal Employment Opportunity Statement: CU is an Equal Opportunity Employer and complies with all
-
on your paycheck. The University of Colorado provides generous leave, health plans and retirement contributions that add to your bottom line. Total Compensation Calculator: http://www.cu.edu/node/153125
-
your bottom line. Total Compensation Calculator: http://www.cu.edu/node/153125 Equal Employment Opportunity Statement: The University of Colorado (CU) is an Equal Opportunity Employer and complies with
-
oncogenic cell states. To investigate these questions, we combine molecular biology, cancer biology, and genomics, including long-read RNA sequencing, RNA-targeting CRISPR, and computational analysis. We